stockportfolio.pro
Stocks / CC vs CLMT
CC vs CLMT
The Chemours Company and Calumet, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Basic Materials.
| The Chemours Company (CC) | Calumet, Inc. (CLMT) | |
|---|---|---|
| Market cap | $3.1B | $3.1B |
| Revenue (latest FY) | $5.81B | $4.14B |
| Net income (latest FY) | $-386.00M | $-33.80M |
| Revenue growth (5y CAGR) | 3.2% | -4.1% |
| Net margin | -6.6% | -0.8% |
| Return on equity | -154.4% | 4.6% |
| P/E ratio | — | — |
| Dividend yield | 1.7% | — |
| Profitable years (of last 10) | 7 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CC — free Open CLMT — freeFrequently asked questions
Which is bigger, CC or CLMT?
The Chemours Company is larger by market capitalization — $3.1B versus $3.1B.
Which grows faster, CC or CLMT?
Over the last five fiscal years, The Chemours Company grew revenue faster — 3.2%/yr versus -4.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.